Poor Asthma Control

SAN DIEGO — Patients with moderate to severe asthma who were treated with rilzabrutinib showed a reduction in loss of asthma control events, according to a study presented at the American Thoracic Society International Conference.

WASHINGTON — Among children with asthma, poor disease control was linked to receipt of food stamps and trouble affording medication, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Among adults with asthma living in Chicago, poorly controlled asthma was linked to Black race and a low education level, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Adults with moderate to severe persistent asthma receiving rademikibart every 2 weeks showed greater improvements in lung function at week 12 compared with patients assigned placebo, according to topline results from a phase 2b trial.

Inhaler technique often worsens within 12 months of instruction, with many patients experiencing deterioration in technique 1 to 3 months after instruction, according to a recent study.

SAN ANTONIO — Elevated cognitive impairment appeared linked to weak asthma control among older adults, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Publicly insured children were more likely to have issues controlling their asthma than privately insured children, according to data presented at American Academy of Allergy, Asthma & Immunology Annual Meeting.

In a new study, novel metrics showed that lower time adherence to asthma controller medications was associated with greater risk for decline in asthma symptom control.